allergenic extracts - standardized mite dermatophagoides pteronyssinus liquid
greer laboratories inc - dermatophagoides pteronyssinus - liquid - 30000unit - dermatophagoides pteronyssinus 30000unit - allergenic extracts
acarizax 12 sq-hdm oral lyophilisates
imported (denmark) - dermatophagoides farinae allergen extract; dermatophagoides pteronyssinus allergen extract - oral lyophilisate
acarizax 12 sq-hdm oral lyophilisates
alk-abello ltd - dermatophagoides farinae allergen extract; dermatophagoides pteronyssinus allergen extract - oral lyophilisate
house dust mite mix 100dbu/ml solution for skin prick test
lofarma - dermatophagoides farinae allergen extract; dermatophagoides pteronyssinus allergen extract - solution for skin-prick test
dermatophagoides pteronyssinus 10,000du/ml odc solution for skin prick test
allergy therapeutics (uk) ltd - dermatophagoides pteronyssinus allergen extract - solution for skin-prick test
standardized mite mix, dermatophagoides pteronyssinus and dermatophagoides farinae, 10000 au per ml injection, solution standar
jubilant hollisterstier llc - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k) - dermatophagoides farinae 5000 [au] in 1 ml - 16, 17, 18, 26 standardized glycerinated allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing.20, 21 the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed allergen. allergens to which a patient is extremely sensitive should not be included in treatment mixes with
treatment set ts342922 injection, solution
antigen laboratories, inc. - dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), acer negundo pollen (unii: p6k070ar8v) (acer negundo pollen - unii:p6k070ar8v), felis catus hair (unii: 1564hd0n96) (felis c - dermatophagoides pteronyssinus 16 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski
treatment set ts336924 injection, solution treatment set ts336312 injection, solution
antigen laboratories, inc. - dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig), cladosporium herbarum (unii: o64jf11198) (cladosporium herbarum - unii:o64jf11198), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), alternaria alternata (uni - dermatophagoides pteronyssinus 400 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski
dermatophagoides pteronyssinus 50,000sbu/ml solution for skin prick test
allergopharma - dermatophagoides pteronyssinus allergen extract - solution for skin-prick test
dermatophagoides pteronyssinus 100hep/ml solution for skin prick test
inmunotek - dermatophagoides pteronyssinus allergen extract - solution for skin-prick test